ChengDu ShengNuo Biotec Co.,Ltd.
public_traded
ChengDu ShengNuo Biotec Co.,Ltd. is publicly traded on SHH under ticker 688117.SS.
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company produces polypeptide APIs, tablets of solid preparation, bottles of freeze-dried powder injections, small-volume injections, pre-filled injections, and card type injections. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.